⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Levicept Announces the Appointment of James Sandy as Chief Development Officer
globenewswire.com
PFE
AZN
Publicis Advances Working With Cancer with initiative to support 40 million workers worldwide
globenewswire.com
DIS
GOOG
ZETA
TT
CMCSA
PARA
IHRT
WRLD
WMT
PFE
BCS
ACN
CAR
Clinical Trials Support Service Market to Reach US$ 47.1 Billion by 2032 Driven by Rising Trial Complexity, Patient-Centric Models, and AI-Based Trial Management | Astute Analytica
globenewswire.com
PFE
MRK
JNJ
BMY
GILD
AMGN
REGN
LLY
ABBV
AZN
In-Vitro Toxicology Testing Market to Reach US$ 57.55 Billion by 2033 Supported by OECD Guidelines, EPA NAM Framework, and EU Cosmetics Regulation Says Astute Analytica
globenewswire.com
CRL
AMGN
BMY
MRK
PFE
JNJ
COVID-19 Diagnostic Research Report 2026: Market Forecast 2025-2029 with Executive and Consultant Guides
globenewswire.com
ABT
BDX
BIO
CDNA
CUE
DHR
GILD
HOLX
ILMN
JNJ
LAB
LMT
LULU
MRNA
ON
ORGO
OTIS
PFE
QCOM
QGEN
QDEL
REGN
RTX
SIGA
SNPS
TCOM
TDOC
TEVA
TMO
TSLA
VRTX
XOM
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME
Antimicrobial Resistance Diagnostic Research Report 2026: Markets, Strategies, Trends and Forecasts 2025-2029 by Pathogen and Technology with Executive Guides and Customization
globenewswire.com
BIOX
MRNA
PFE
TMO
ILMN
QGEN
DGX
ABT
BDX
HOLX
EXAS
DHR
Syndromic Multiplex Panels Market Strategies, Trends and Forecast 2025-2029: Cost Efficiency, Diagnostic Accuracy, Single-Visit Testing, and Pandemic-Driven Uptake Support Growth
globenewswire.com
ABT
BDX
BIIB
CHE
CTAS
CUE
DHR
DIA
EXPE
GEHC
GILD
HOLX
ICUI
ILMN
INCY
ISRG
LH
LULU
MRNA
NBIX
NOC
ORCL
PDD
PFE
QGEN
QDEL
REGN
ROKU
SNPS
TMO
TSLA
VRTX
XRAY
Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance
businesswire.com
PFE
Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial
businesswire.com
PFE